ArticleCancers2020

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI).

Andrea De Giglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.